ReviewLab on a chip2014
Microfluidic assembly of multistage porous silicon-lipid vesicles for controlled drug release.
Review in Lab on a chip, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Design automation of microfluidic single and double emulsion droplets with machine learning.Nature communications · 2024Article
- Microfluidic Droplet-Generation Device with Flexible Walls.Micromachines · 2023Article
- Recent Advances in Drug Delivery System Fabricated by Microfluidics for Disease Therapy.Bioengineering (Basel, Switzerland) · 2022Review
- Simple One-Step and Rapid Patterning of PDMS Microfluidic Device Wettability for PDMS Shell Production.Frontiers in bioengineering and biotechnology · 2022Article
- Sorafenib Repurposing for Ophthalmic Delivery by Lipid Nanoparticles: A Preliminary Study.Pharmaceutics · 2021Article
- Fabrication of Multi-Layered Microspheres Based on Phase Separation for Drug Delivery.Micromachines · 2021Article
- High-Throughput Production of Micrometer Sized Double Emulsions and Microgel Capsules in Parallelized 3D Printed Microfluidic Devices.Polymers · 2019Article
- Exploring the water/oil/water interface of phospholipid stabilized double emulsions by micro-focusing synchrotron SAXS.RSC advances · 2019Article
- Photothermal-responsive nanosized hybrid polymersome as versatile therapeutics codelivery nanovehicle for effective tumor suppression.Proceedings of the National Academy of Sciences of the United States of America · 2019Article
- Review
- Enhancement of Peroxidase Stability Against Oxidative Self-Inactivation by Co-immobilization with a Redox-Active Protein in Mesoporous Silicon and Silica Microparticles.Nanoscale research letters · 2016Article
- A Microfluidic Platform to design crosslinked Hyaluronic Acid Nanoparticles (cHANPs) for enhanced MRI.Scientific reports · 2016Article
- CO2-breathing and piercing polymersomes as tunable and reversible nanocarriers.Scientific reports · 2016Article
- Sustained release of hydrophobic drugs by the microfluidic assembly of multistage microgel/poly (lactic-co-glycolic acid) nanoparticle composites.Biomicrofluidics · 2015Article
- Microencapsulation of indocyanine green for potential applications in image-guided drug delivery.Lab on a chip · 2015Article
- Amine-modified hyaluronic acid-functionalized porous silicon nanoparticles for targeting breast cancer tumors.Nanoscale · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
A reliable microfluidic platform for the generation of stable and monodisperse multistage drug delivery systems is reported. A glass-capillary flow-focusing droplet generation device was used to encapsulate thermally hydrocarbonized porous silicon (PSi) microparticles into the aqueous cores of double emulsion drops, yielding the formation of a multistage PSi-lipid vesicle. This composite system enables a large loading capacity for hydrophobic drugs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.